|
Secondary prevention
Citations 341-350 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Differences in Medical Care and Disease Outcomes Among Black and White Women With Heart Disease
- Ashish K. Jha, Paul D. Varosy, Alka M. Kanaya, Donald B. Hunninghake, Mark A. Hlatky, David D. Waters, Curt D. Furberg, and Michael G. Shlipak
Circulation published August 25, 2003, doi:10.1161/01.CIR.0000085994.38132.E5
[Abstract]
- Clinical Investigations and Reports
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease
- Eric J. Topol, Donald Easton, Robert A. Harrington, Pierre Amarenco, Robert M. Califf, Carmen Graffagnino, Stephen Davis, Hans-Christophe Diener, James Ferguson, Desmond Fitzgerald, Jeffrey Granett, Ashfaq Shuaib, Peter J. Koudstaal, Pierre Theroux, Frans Van de Werf, Kristina Sigmon, Karen Pieper, Marc Vallee, and James T. Willerson
Circulation 2003;108:399-406; published online before print as doi:10.1161/01.CIR.0000084501.48570.F6
[Abstract]
[Full text]
- Clinical Investigations and Reports
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
- Mehdi H. Shishehbor, Marie-Luise Brennan, Ronnier J. Aviles, Xiaoming Fu, Marc S. Penn, Dennis L. Sprecher, and Stanley L. Hazen
Circulation 2003;108:426-431; published online before print as doi:10.1161/01.CIR.0000080895.05158.8B
[Abstract]
[Full text]
- Corrections
Correction
-
Circulation 2003;108:501-a, doi:10.1161/01.CIR.0000085808.46240.FC
[Full text]
- Cardiology Patient Pages
What Is an Angiotensin Converting Enzyme Inhibitor?
- Nancy K. Sweitzer
Circulation 2003;108:e16-18e, doi:10.1161/01.CIR.0000075957.16003.07
[Full text]
- Clinical Investigations and Reports
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease
- Eric J. Topol, Donald Easton, Robert A. Harrington, Pierre Amarenco, Robert M. Califf, Carmen Graffagnino, Stephen Davis, Hans-Christophe Diener, James Ferguson, Desmond Fitzgerald, Jeffrey Granett, Ashfaq Shuaib, Peter J. Koudstaal, Pierre Theroux, Frans Van de Werf, Kristina Sigmon, Karen Pieper, Marc Vallee, and James T. Willerson
Circulation published July 21, 2003, doi:10.1161/01.CIR.0000084501.48570.F6
[Abstract]
[Full text]
- Clinical Investigations and Reports
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
- Mehdi H. Shishehbor, Marie-Luise Brennan, Ronnier J. Aviles, Xiaoming Fu, Marc S. Penn, Dennis L. Sprecher, and Stanley L. Hazen
Circulation published July 14, 2003, doi:10.1161/01.CIR.0000080895.05158.8B
[Abstract]
- Clinician Update
Perspectives in Cholesterol-Lowering Therapy: The Role of Ezetimibe, a New Selective Inhibitor of Intestinal Cholesterol Absorption
- Eric Bruckert, Philippe Giral, and Philippe Tellier
Circulation 2003;107:3124-3128, doi:10.1161/01.CIR.0000072345.98581.24
[Full text]
- AHA Scientific Statements
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease: A Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)
- Paul D. Thompson, David Buchner, Ileana L. Piña, Gary J. Balady, Mark A. Williams, Bess H. Marcus, Kathy Berra, Steven N. Blair, Fernando Costa, Barry Franklin, Gerald F. Fletcher, Neil F. Gordon, Russell R. Pate, Beatriz L. Rodriguez, Antronette K. Yancey, and Nanette K. Wenger
Circulation 2003;107:3109-3116, doi:10.1161/01.CIR.0000075572.40158.77
[Full text]
- Clinician Update
Unstable Angina and Non–ST-Elevation Myocardial Infarction: Initial Antithrombotic Therapy and Early Invasive Strategy
- Christopher P. Cannon and Alexander G.G. Turpie
Circulation 2003;107:2640-2645, doi:10.1161/01.CIR.0000072246.69344.2D
[Full text]
|
|
